Skip to main content
. 2022 Feb 11;23:64. doi: 10.1186/s12882-022-02692-z

Fig. 1.

Fig. 1

Circulatory levels of NGAL, IGFBP-1, IGFBP-3, and IGFBP-4the 3 study groups: non-diabetic (n = 42), T2D (n = 50) and DN (n = 67). A Circulating level of NGAL B Circulating level of IGFBP-1 (C) Circulating level of IGFBP-3 (D) Circulating level of IGFBP-4, statistical significance is presented when p-value < 0.05